• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高亲和力抗人结肠肿瘤小鼠/人嵌合抗体的基因工程

Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

作者信息

Xiang J, Chen Z

机构信息

Saskatoon Cancer Centre, University of Saskatchewan, Canada.

出版信息

Immunology. 1992 Feb;75(2):209-16.

PMID:1551684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1384696/
Abstract

Two amino acids, tyrosine at position 96 and histidine at position 99 in the variable heavy chain (VH) CDR3 region of a mouse/human chimeric anti-TAG72 antibody cB72.3-1-3 were substituted with phenylalanine and asparagine respectively by site-directed mutagenesis technique. The expression vector mpSV2neo-EP1-Vm1-3-C gamma 1 containing mutant VH region fragments (Vm1-3) as well as the immunoglobulin enhancer (E), promoter (P1) and human genomic C gamma 1 region fragments, was transfected into a heavy-chain loss mutant cell line B72.3Mut(k). Mutant chimeric cB72.3m1-3 antibodies were purified from the transfectant supernates and compared based upon their binding affinity for the TAG72 antigen relative to that of the original cB72.3-1-3 antibody. The data show that a single amino acid substitution of histidine with asparagine at position 99 in VH CDR3 region contributes to four times increase in binding affinity for the TAG72 antigen. This suggests that the residue at position 99 in VH CDR3 region may play some role in antibody/antigen (B72.3/TAG72) interaction.

摘要

通过定点诱变技术,将小鼠/人嵌合抗TAG72抗体cB72.3-1-3可变重链(VH)CDR3区域中第96位的酪氨酸和第99位的组氨酸这两个氨基酸分别替换为苯丙氨酸和天冬酰胺。将含有突变VH区域片段(Vm1-3)以及免疫球蛋白增强子(E)、启动子(P1)和人基因组Cγ1区域片段的表达载体mpSV2neo-EP1-Vm1-3-Cγ1转染至重链缺失突变细胞系B72.3Mut(k)。从转染细胞的上清液中纯化出突变嵌合cB72.3m1-3抗体,并将其与原始cB72.3-1-3抗体对TAG72抗原的结合亲和力进行比较。数据表明,VH CDR3区域第99位的组氨酸被天冬酰胺单氨基酸取代后,对TAG72抗原的结合亲和力增加了四倍。这表明VH CDR3区域第99位的残基可能在抗体/抗原(B72.3/TAG72)相互作用中发挥一定作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/ac4df2f9b30f/immunology00109-0007-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/eeee95877b43/immunology00109-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/4cf5df5a24a2/immunology00109-0007-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/ac4df2f9b30f/immunology00109-0007-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/eeee95877b43/immunology00109-0007-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/4cf5df5a24a2/immunology00109-0007-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d0c/1384696/ac4df2f9b30f/immunology00109-0007-c.jpg

相似文献

1
Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.高亲和力抗人结肠肿瘤小鼠/人嵌合抗体的基因工程
Immunology. 1992 Feb;75(2):209-16.
2
The tyrosine residue at position 97 in the VH CDR3 region of a mouse/human chimeric anti-colorectal carcinoma antibody contributes hydrogen bonding to the TAG72 antigen.小鼠/人嵌合抗结直肠癌抗体的VH CDR3区域第97位的酪氨酸残基与TAG72抗原形成氢键。
Cancer Biother. 1993 Fall;8(3):253-62. doi: 10.1089/cbr.1993.8.253.
3
Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain.重链可变区单个氨基酸取代导致的抗原结合亲和力差异。
Immunol Cell Biol. 1993 Aug;71 ( Pt 4):239-47. doi: 10.1038/icb.1993.28.
4
Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.高亲和力嵌合抗结直肠癌抗体ccM4的构建与表征
Mol Biother. 1992 Dec;4(4):174-83.
5
Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.重组小鼠/人嵌合抗结直肠癌抗体cACT19
Hum Antibodies Hybridomas. 1994;5(3-4):105-15.
6
Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.通过蛋白质工程制备双功能杂交分子B72.3/金属硫蛋白-1。
Immunology. 1993 Apr;78(4):574-81.
7
Genetic engineering of anticolorectal carcinoma Fv molecule in myeloma cells.骨髓瘤细胞中抗结直肠癌Fv分子的基因工程
Mol Biother. 1992 Jun;4(2):70-6.
8
Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).重组/嵌合B72.3(人γ1)的产生与特性分析
Cancer Res. 1991 Jan 1;51(1):181-9.
9
Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.嵌合B72.3抗体的框架残基71和93是重链高变环构象的主要决定因素。
J Mol Biol. 1995 Oct 27;253(3):385-90. doi: 10.1006/jmbi.1995.0560.
10
Modification in framework region I results in a decreased affinity of chimeric anti-TAG72 antibody.框架区I的修饰导致嵌合抗TAG72抗体的亲和力降低。
Mol Immunol. 1991 Jan-Feb;28(1-2):141-8. doi: 10.1016/0161-5890(91)90097-4.

引用本文的文献

1
Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.用于表达具有人恒定区的PCR扩增免疫球蛋白可变结构域的载体。
Nucleic Acids Res. 1993 Jun 25;21(12):2921-9. doi: 10.1093/nar/21.12.2921.
2
High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging.高亲和力嵌合抗(结肠直肠癌)抗体与生物分布和成像中增强的肿瘤靶向性相关。
J Cancer Res Clin Oncol. 1993;120(1-2):57-62. doi: 10.1007/BF01200725.
3
Autologous human B-cell immune response to pulmonary adenocarcinomatous polymorphic epithelial mucin.

本文引用的文献

1
Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas.单克隆抗体与人结肠腺癌和腺瘤的差异反应性。
Int J Cancer. 1983 May 15;31(5):543-52. doi: 10.1002/ijc.2910310504.
2
Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.通过单克隆抗体对无胸腺小鼠体内人乳腺肿瘤进行放射性定位。
Cancer Res. 1983 Feb;43(2):736-42.
3
Single amino acid substitution altering antigen-binding specificity.单个氨基酸取代改变抗原结合特异性。
人类自体B细胞对肺腺癌多形性上皮粘蛋白的免疫反应。
J Clin Immunol. 1995 Mar;15(2):74-9. doi: 10.1007/BF01541735.
Proc Natl Acad Sci U S A. 1982 Mar;79(6):1979-83. doi: 10.1073/pnas.79.6.1979.
4
Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.通过电穿孔导入小鼠前B淋巴细胞的人κ免疫球蛋白基因的增强子依赖性表达。
Proc Natl Acad Sci U S A. 1984 Nov;81(22):7161-5. doi: 10.1073/pnas.81.22.7161.
5
Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies.淋巴细胞杂交瘤的生物学及临床意义:单克隆抗体肿瘤治疗
Annu Rev Med. 1983;34:107-16. doi: 10.1146/annurev.me.34.020183.000543.
6
A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.一种单克隆抗体(B72.3)确定了一种新型肿瘤相关抗原在人乳腺癌细胞群体中的分布模式。
Int J Cancer. 1982 May 15;29(5):539-45. doi: 10.1002/ijc.2910290509.
7
Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors.克隆至M13载体的DNA片段的寡核苷酸定向诱变
Methods Enzymol. 1983;100:468-500. doi: 10.1016/0076-6879(83)00074-9.
8
Galactan-binding antibodies. Diversity and structure of idiotypes.半乳聚糖结合抗体。独特型的多样性与结构。
J Exp Med. 1983 Nov 1;158(5):1385-400. doi: 10.1084/jem.158.5.1385.
9
Structural correlates of cross-reactive and individual idiotypic determinants on murine antibodies to alpha-(1 leads to 3) dextran.小鼠抗α-(1→3)葡聚糖抗体上交叉反应性和个体独特型决定簇的结构关联
J Exp Med. 1980 May 1;151(5):1059-70. doi: 10.1084/jem.151.5.1059.
10
Production of functional chimaeric mouse/human antibody.功能性嵌合小鼠/人抗体的产生。
Nature. 1984;312(5995):643-6. doi: 10.1038/312643a0.